Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Testosterone increases sexual behavior in female capuchin monkeys.

The 0.25% finasteride solution, when applied once a day, effectively reduces scalp DHT, potentially minimizing sexual side-effects linked to a systemic DHT reduction.

Dihydrotestosterone gel before hypospadias surgery led to less scarring but raised concerns about potential psychological effects and skin changes.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Domestic and imported finasteride tablets work the same in the body.

Most patients were satisfied with topical finasteride, and few experienced side effects.

Hormones like testosterone affect skin functions and can cause skin issues when in excess; treatments to manage these effects are only somewhat effective.

Finasteride safely lowers DHT levels without affecting testosterone.

Men with COVID-19 have different hormone levels linked to disease severity.

Microgravity may increase drug bioavailability, potentially reaching up to 80%.

Low zinc levels are linked to low testosterone but not to sexual problems.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Women have a higher DHT/testosterone ratio than men, possibly due to gut bacteria activity.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Testosterone therapy improved symptoms in a woman with congenital adrenal hyperplasia.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Testosterone increases heart and blood pressure issues in rats with endotoxemia, and stopping testosterone production can reduce these problems.

A woman got male pattern baldness from touching her husband's testosterone gel.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.